Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot Topics Symposium At The Aesthetic Meeting 2018

DUBLIN, April 27, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the presentation of clinical data from a Phase 2b investigational study of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. Dr. Lawrence Bass, a New York City-based,...

from PR Newswire: //https://ift.tt/2KhuAlf